BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9871746)

  • 1. 3-trifluoromethylcarbacephems: synthesis of broad spectrum antibacterial compounds.
    Cook GK; Hornback WJ; McDonald JH; Munroe JE; Snyder NJ
    Bioorg Med Chem Lett; 1998 May; 8(10):1261-6. PubMed ID: 9871746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity and beta-lactamase stability of the oral cephalosporin BMY-28100.
    Hiraoka M; Masuyoshi S; Tomatsu K; Inoue M; Mitsuhashi S
    Eur J Clin Microbiol; 1987 Oct; 6(5):559-63. PubMed ID: 3501756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antibacterial activity of novel 3-substituted carbacephems.
    Mochida K; Ogasa T; Shimada J; Hirata T; Sato K; Okachi R
    J Antibiot (Tokyo); 1989 Feb; 42(2):283-92. PubMed ID: 2925519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemophilus influenzae bla(ROB-1) mutations in hypermutagenic deltaampC Escherichia coli conferring resistance to cefotaxime and beta-lactamase inhibitors and increased susceptibility to cefaclor.
    Galán JC; Morosini MI; Baquero MR; Reig M; Baquero F
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2551-7. PubMed ID: 12878518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro activity of cefaclor (author's transl)].
    Knothe H
    Infection; 1979; 7 Suppl 6():518-26. PubMed ID: 45087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminothiazolylglycyl derivatives of carbacephems. I. Synthesis and antibacterial activity of novel carbacephems with substituted aminothiazolyl groups.
    Mochida K; Shiraki C; Yamasaki M; Hirata T; Sato K; Okachi R
    J Antibiot (Tokyo); 1987 Jan; 40(1):14-21. PubMed ID: 3558115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of ceftobiprole activity against a variety of gram-negative pathogens, including Escherichia coli, Haemophilus influenzae (β-lactamase positive and β-lactamase negative), and Klebsiella pneumoniae, in a rabbit meningitis model.
    Stucki A; Cottagnoud M; Acosta F; Egerman U; Läuffer J; Cottagnoud P
    Antimicrob Agents Chemother; 2012 Feb; 56(2):921-5. PubMed ID: 22064544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activity of a new cephalosporin, cefotaxime.
    Russell AD; Rogers DT
    J Appl Bacteriol; 1980 Aug; 49(1):137-41. PubMed ID: 6253429
    [No Abstract]   [Full Text] [Related]  

  • 10. Summary of laboratory studies on the antibacterial activity of cefaclor.
    Preston DA
    Postgrad Med J; 1979; 55 Suppl 4():22-9. PubMed ID: 398479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NB2001, a novel antibacterial agent with broad-spectrum activity and enhanced potency against beta-lactamase-producing strains.
    Li Q; Lee JY; Castillo R; Hixon MS; Pujol C; Doppalapudi VR; Shepard HM; Wahl GM; Lobl TJ; Chan MF
    Antimicrob Agents Chemother; 2002 May; 46(5):1262-8. PubMed ID: 11959554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemistry of cephalosporin antibiotics. XXIV. 3-Halo- and 3-methoxy-3-cephems.
    Chauvette RR; Pennington PA
    J Am Chem Soc; 1974 Jul; 96(15):4986-7. PubMed ID: 4604213
    [No Abstract]   [Full Text] [Related]  

  • 13. Ceftibuten and bactericidal kinetics. Comparative in vitro activity against Enterobacteriaceae producing extended spectrum beta-lactamases.
    Bauernfeind A
    Diagn Microbiol Infect Dis; 1991; 14(1):89-92. PubMed ID: 2013215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in-vitro activity of a new oral carbacephem, LY163892.
    Howard AJ; Dunkin KT
    J Antimicrob Chemother; 1988 Oct; 22(4):445-56. PubMed ID: 3060458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of a series of parenteral 3'-quaternary ammonium cephalosporins.
    Brown RF; Kinnick MD; Morin JM; Vasileff RT; Counter FT; Davidson EO; Ensminger PW; Eudaly JA; Kasher JS; Katner AS
    J Med Chem; 1990 Aug; 33(8):2114-21. PubMed ID: 2115587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationship of new cephalosporins with amino heterocycles at C-7. Dependence of the antibacterial spectrum and beta-lactamase stability on the pKa of the C-7 heterocycle.
    Jung F; Delvare C; Boucherot D; Hamon A; Ackerley N; Betts MJ
    J Med Chem; 1991 Mar; 34(3):1110-6. PubMed ID: 2002452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-lactamase stability and antibacterial activity of cefpirome alone and in combination with other antibiotics.
    Bakhtiar M; Selwyn S
    Drugs Exp Clin Res; 1989; 15(10):477-82. PubMed ID: 2698794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory studies with BL-S 578 (Cefadroxil) a new broad-spectrum orally active cephalosporin.
    Ripa S; Prenna M
    Chemotherapy; 1979; 25(1):9-13. PubMed ID: 33784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial activity of cefamandole in vitro.
    Meyers BR; Hirschman SZ
    J Infect Dis; 1978 May; 137 Suppl():S25-S31. PubMed ID: 349095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial activity of cefcanel.
    Bergan T; da Fonseca J
    Chemotherapy; 1993; 39(2):96-104. PubMed ID: 8458252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.